TP0472993

N/A

Report date: 2023/08/22 10:02:40
NME

Base Information

Drug NameTP0472993
Drug Alias NameTP0472993TP-0472993
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action20-hydroxyeicosatetraenoic acid synthesis inhibitors
Targets20-hydroxyeicosatetraenoic acid
Therapy Area/IndicationsRenal fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaisho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A